12/17
07:46 am
cgen
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million [Yahoo! Finance]
High
Report
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million [Yahoo! Finance]
12/17
07:00 am
cgen
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
Low
Report
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
11/10
07:11 am
cgen
Compugen Reports Third Quarter 2025 Results [Yahoo! Finance]
Low
Report
Compugen Reports Third Quarter 2025 Results [Yahoo! Finance]
11/10
07:00 am
cgen
Compugen Reports Third Quarter 2025 Results
Medium
Report
Compugen Reports Third Quarter 2025 Results
11/4
07:00 am
cgen
Compugen to Participate in Stifel 2025 Healthcare Conference
Medium
Report
Compugen to Participate in Stifel 2025 Healthcare Conference
10/27
07:00 am
cgen
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
Medium
Report
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
10/13
07:34 am
cgen
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 [Yahoo! Finance]
Medium
Report
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 [Yahoo! Finance]
10/13
07:00 am
cgen
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025
High
Report
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025
10/6
07:00 am
cgen
Compugen to Present at SITC 2025
Medium
Report
Compugen to Present at SITC 2025